Press release from Companies
Published: 2025-05-02 15:00:38
This notice is given to the shareholders of Eevia Health Abp (Plc) for an Extraordinary General Meeting to be held on May 30, 2025, at noon (Finnish time GMT +3) at the main office of Eevia Health Abp in Koulukatu 14, Seinäjoki, Finland. The reception of persons who have registered for the meeting and the distribution of voting tickets will commence at 11:00.
The Extraordinary General Meeting will handle the following matters:
There is some uncertainty if the Limited Liability Company Act precedes the Company Act in Finnish Law when it comes to substituting for an open Board position. There are some arguments that the Board cannot supplement vacancies as stipulated in the Limited Companies Act. The Board does not agree with this interpretation, but for prudency the Board asks the General Meeting to confirm the election of Marinus Blåbjerg Sørensen as a member of the Board to fill the vacancy that emerged in January. Currently, he is not registered as a member in the Patent and registration Authorities in Finland but listed as a Board member in other locations and taking part in Board meetings. The term of office will continue until the next Annual General Meeting as stipulated in the Articles of Association.
The Extraordinary General Meeting on November 4, 2024 resolved regarding the remuneration to the Board, which included that a main part of the compensation will be done by issuing the Board with shares. For practical reasons, Eevia wishes that the shares to Board members for the current period would be issued as part of a planned direct placement, to avoid costs with separate issuance procedures. Shares will be issued during May 2025 according to the November 4th decision, and subject to the confirmation by the GM on 30.5.25 the share can be registered together with other share issuances when convenient.
There has been request from shareholders to make changes to Eevia’s Nomination Board. A proposal for new members to the Nomination Board will be made by key shareholders and presented before or at the General Meeting.
An option program was handled by the AGM in 2024, but options were not issued. The Board wishes to initiate an incentive program and issue options, but to avoid this being done outside the frames set by a GM approved option program, the Board is seeking the approval from the General Meeting for an updated Option program. An updated Option program will be made available to shareholders on Eevia’s web pages before May 9th, 2025.
The Board is working to execute a private placement of shares and seeking investors for this purpose. There could be a situation that the placement will be directed to insiders and/or PMDRs, especially if no other investor is to be found who is interested in investing. Hence, if the search for external investors has been exhausted, we may ask insiders to subscribe.
According to Spotlight Regulation, a placement with insiders must be approved by the general meeting. Therefore, to avoid any risks, if this situation should occur, a pre-emptive approval should be asked for, so that the Company may also direct a placement to insiders, if needed.
This notice, including all the proposals relating to the agenda of the General Meeting, is available on Eevia Health Abp’s website at www.eeviahealth.com. by May 6th. The documents mentioned above will also be available at the meeting. Minutes of the General Meeting will be made available on the website mentioned above.
Each shareholder registered on May 19, 2025, in the Company's shareholders' register held by Euroclear Finland Ltd. has the right to participate in the General Meeting. A shareholder whose shares are registered on their Finnish book-entry account is registered in the Company's shareholders register.
A shareholder who wants to participate in the General Meeting shall register for the meeting by May 26, 2025, at 16:00 (Finnish time), by which time the registration shall be received. The registration may take place:
a) By email to address info@eeviahealth.com;
b) by mail to Eevia Health Abp, General Meeting, Koulukatu 14, 60100 Seinäjoki, Finland.
The requested information shall be given in connection with the registration, such as name, personal identification number, address, email address, the name of a possible assistant or proxy representative, and the personal identification number of a proxy representative. The personal data given to Eevia Health Abp is used only in connection with the General Meeting and the processing of related necessary registrations and for shareholder communication. Shareholder, his/her/its representative or proxy representative shall, when required, be able to prove his/her/its identity and right of representation.
A holder of nominee-registered shares has the right to participate in the General Meeting by virtue of shares based on which he/she/it on the record date of the meeting, i.e., on May 19, 2025, would be entitled to be registered in the shareholders' register of the Company held by Euroclear Finland Ltd. The right to participate in the General Meeting requires, in addition, that the shareholder has, on the basis of such shares, been registered into the temporary shareholders' register of the Company held by Euroclear Finland Ltd. at the latest on May 26, 2025, by 10:00 (Finnish time). Regarding nominee-registered shares, this constitutes a due registration for the General Meeting.
A holder of nominee-registered shares is advised without delay to request necessary instructions regarding the registration in the temporary shareholder's register of the Company, the issuing of proxy documents, and registration for the General Meeting from their custodian bank. The account management organization of the custodian bank must register a holder of nominee-registered shares who wants to participate in the General Meeting into the temporary shareholders' register of the Company at the latest on the date and time mentioned above.
Shareholders whose shares are registered in Euroclear Sweden AB's securities system and who want to participate in the General Meeting and use their voting rights shall be registered at the shareholder's register held by Euroclear Sweden AB on May 19, 2025, at the latest.
To be entitled to request for temporary registration in the shareholder’s register of Eevia Health Abp held by Euroclear Finland Ltd., a shareholder of nominee-registered shares shall request that his/her/its shares be temporarily registered under his/her/its name in the shareholder's register held by Euroclear Sweden AB and to ensure that the custodian bank will send the request mentioned above for temporary registration to Euroclear Sweden AB. Registration shall be made on May 26 2025 at the latest; therefore, a shareholder shall request his/her/custodian bank before the above date.
A shareholder whose shares are registered in the securities system of Euroclear Sweden AB and who intends to participate in the General Meeting and use his/her/its voting right shall request for temporary registration of his/her shares to the shareholder's register of Eevia Health Abp held by Euroclear Finland Ltd. The request to Eevia Health Abp shall be made in writing at the latest on May 26, 2025, at 10:00 (Swedish time). The temporary registration through Eevia Health Abp constitutes due registration for the General Meeting.
A shareholder may participate in the General Meeting and exercise his/her/its rights at the meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise provide reliable evidence of the right to represent the shareholder. The authorization applies to one meeting unless otherwise stated. When a shareholder participates in the General Meeting using several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the General Meeting.
Possible proxy documents should be delivered via email to info@eeviahealth.com or by mail to Eevia Health Abp, General Meeting, Koulukatu 14, 60100 Seinäjoki, Finland, before the end of the registration period.
Pursuant to Chapter 5 Section 25 of the Finnish Companies Act, a shareholder at the General Meeting has the right to request information concerning the matters to be handled at the meeting.
On the date of the notice to the General Meeting, May 2, 2025, the total number of shares in Eevia Health Abp is 126,842,805. Each share carries one vote at the General Meeting.
Seinäjoki, May 2, 2025 EEVIA HEALTH ABP
Board of Directors
For more information:
Stein Ulve, CEO, Eevia Health Abp
mail: stein.ulve@eeviahealth.com
Te.: +358 400 22 5967
About Eevia
Eevia Health Plc, founded in March 2017, addresses global health challenges with bioactive compounds sustainably extracted from renewable plant materials. It focuses on the gut and related health, including kidney and urinary health.
Eevia Health is a manufacturer of 100% organically certified plant extracts. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.
As a pioneering company, Eevia is developing high-value food ingredients, blended solutions, and biomaterials that significantly benefit human health. Eevia Health operates a modern green-chemistry production facility in Finland with a short value chain and environmentally friendly carbon footprint. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.
